Maxim Yakovlev, a Russian businessman: a biography, the path to success
Maxim Yakovlev - St. Petersburgentrepreneur, director of the Polygraphoformlenie group of companies, director of the European representation of the biotechnology corporation Unhwa and partner of the online project EduMarket, which allows interested people in education to have an opportunity to develop their careers, and also to engage in personal growth.
The future businessman was born on November 30, 1965 in the city of Temirtau (now - the Republic of Kazakhstan).
The company "Polygraphformlenie", headed byMaxim Yakovlev since 1994, has its history from the distant 1879, this time was marked by the creation of E.I. Marcus chromolithography in St. Petersburg, on the Vasilievsky Island. After the revolution of 1917, the enterprise was renamed State Lithography No3, and in 1974 it merged with Polygraphic Factory No17, after which a new name, Polygraphformlenie, appeared. Finally, in 1994, JSC Polygraphformlenie was formed, which at the moment is a group of companies.
Today the company is the largest in the North-West of Russia in the label and packaging production segment, and in the staff of Polygraphformleniya there are more than five hundred employees.
The company operates in four areas - offset production, self-adhesive labels, flexography and packaging by gravure printing.
Since 2002, the company has joined the organizationGlobal Packaging Alliance. This international organization includes companies from all over the world, such as Diamond Packaging, Goncalves, Colorpak, Cartmont and many others.
Today Polygraphformlenie works with large customers, including many well-known brands such as Baltika, Orimi Trade, Wrigley's, Nestle, Dirol, and JTI and BAT.
Biotechnology Unhwa
Maxim Yakovlev has been interested in culture for many yearsEast, and thanks to this hobby, he was able to establish business contacts in Asia. Since 2010, Yakovlev has been managing the European headquarters of the South Korean biotechnology corporation Unhwa, which is called Unhwa Europe LLC and is based in St. Petersburg.
South Korean Biotechnology Corporationdevelops a technology for isolating plant stem cells (Cambial meristematic cells) for obtaining active biological substances from them for the creation of medicinal and preventive preparations, as well as natural cosmetics.
Experts of the institutions of science and education, suchThe Rockefeller University, Harvard Medecal School, and The University of Maryland for Integrative Medicine confirm that this technology is a great step forward compared to traditional technologies for cultivating plant cells for the production of natural products, which faced the problem of creating mass production biologically active substances from cultured plant cells.
St. Petersburg representation of the corporation,which is headed by Maxim Nikolaevich Yakovlev, works with the goal of bringing Biotechnology Unhwa to the domestic market. The company plans to build a plant in Russia that will produce biologically active substances from plants.
